Everforth Inc quarterly report, Q4 FY2009

SEC Filing Summary: On Assignment, Inc. (10-Q)

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare (Nurse Travel and Allied Healthcare), Physician, and IT and Engineering. The company provides contract professionals and direct placement services globally, with primary operations in the U.S., Europe, Canada, Australia, and New Zealand.

Key Financial Metrics

Metric (in thousands) 3 Months Ended Sept 30, 2009 9 Months Ended Sept 30, 2009
Revenues $98,053 $316,689
Gross Profit $32,773 $103,154
Gross Margin 33.4% 32.6%
Operating Income $4,322 $11,589
Net Income $1,454 $3,672
Diluted EPS $0.04 $0.10
Cash and Equivalents $35,068 $35,068 (Balance Sheet)
Operating Cash Flow (9mo) N/A $40,569
Long-Term Debt $82,913 $82,913 (Balance Sheet)
Working Capital $59,781 N/A

Material Changes vs. Prior Period

  • Revenue Decline: Total revenues decreased 39.5% ($63.9 million) for the quarter and 32.7% ($153.8 million) for the nine months compared to 2008. This was driven by weakened demand across all segments due to the economic downturn.
  • Segment Performance:
    • Healthcare: Revenues dropped 56.2% (quarter) and 45.2% (nine months), primarily due to a 64.5% decrease in nurses on assignment and hospital cash constraints.
    • IT and Engineering: Revenues fell 43.5% (quarter) and 38.8% (nine months) due to reduced client capital expenditures.
    • Life Sciences: Revenues declined 33.5% (quarter) and 28.3% (nine months) due to cost containment by clients and softness in clinical trials.
    • Physician: The only segment with growth in the nine-month period (+2.5%), though it declined slightly in the quarter (-4.3%).
  • Margin Expansion: Despite revenue drops, consolidated gross margin expanded 80 basis points for the quarter (to 33.4%) and 50 basis points for the nine months (to 32.6%), aided by cost controls and a shift away from lower-margin Nurse Travel business.
  • Debt Reduction: The company aggressively paid down its term loan, reducing long-term debt from $125.9 million (Dec 31, 2008) to $82.9 million (Sept 30, 2009). Total principal payments in the first nine months of 2009 were $43.0 million.
  • SG&A Efficiency: Selling, general, and administrative expenses decreased 27.4% for the quarter and 22.2% for the nine months, largely due to reduced headcount and lower amortization expenses.

Outlook, Risks, and Management Commentary

  • Outlook: Management anticipates sequential revenue growth in the fourth quarter on a same-number-of-billable-days basis. They expect revenues to stabilize in the second half of 2009 and recover in 2010, though the Nurse Travel segment is expected to see 2010 revenues lower than 2009.
  • Goodwill Impairment: The company performed impairment testing for the Nurse Travel and IT and Engineering reporting units due to market capitalization falling below book value and revenue declines. No impairment was recorded as of September 30, 2009, though the IT and Engineering unit's fair value exceeded its carrying value by only 2.8% as of June 30, 2009.
  • Debt Covenants: The company amended its credit facility in March 2009, modifying leverage ratios and interest rate floors. It remains in compliance and expects to remain so for the next 12 months.
  • Risks: Key risks include the continued negative impact of the global economic slowdown, uncertainty surrounding healthcare reform, and the sensitivity of goodwill valuations to changes in revenue forecasts and discount rates.

Investor Verification Checklist

  • Debt Compliance: Verify continued compliance with the amended credit facility covenants (leverage and interest coverage ratios) given the economic environment.
  • Goodwill Sensitivity: Monitor the IT and Engineering segment closely; its fair value margin over carrying value is thin (2.8% as of Q2), making it highly sensitive to further revenue declines or discount rate increases.
  • Revenue Stabilization: Confirm if the anticipated stabilization of revenues in Q4 2009 materializes, particularly in the heavily impacted Healthcare and IT segments.
  • Cost Savings: Assess the sustainability of the gross margin expansion, which relied partly on reduced travel expenses and lower bill/pay spreads in certain segments.
  • Legal Contingencies: Review the status of the $1.0 million indemnification claim related to the VISTA acquisition, expected to be settled in Q1 2010.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.